31
1 1 Experimental evidences of human 2 coronary microvasculature and myocardial tissue 3 bacterial colonization during meningococcemia. 4 5 Jean Bergounioux 1,2,3 , Mathieu Coureuil 1,4 , Emre Belli 5 , Mohamed Ly 5 , Michelle 6 Cambillau 6 , Nicolas Goudin 7 , Xavier Nassif 1,4,8 and Olivier Join-Lambert 1,4,8 . 7 8 9 10 1 INSERM, U1151, Institut Necker Enfants Malades, Paris, France.; 2Université Versailles Saint Quentin en Yvelines, Versailles France; 3Service 11 de Neurologie et Réanimation pédiatrique, Hôpital Raymond Poincaré, APHP, Garches, France; 4Université Paris Descartes, Sorbonne 12 Paris Cité, Paris, France; 5Centre Chirurgical Marie Lannelongue, Clamard, France; 6Service de Biochimie, Hôpital Européen George 13 Pompidou, APHP, Paris, France 7SFR-Necker Cell Imaging Plateform, Imagine Institut, Paris France 8Laboratoire de Microbiologie 14 Hôpital Necker-Enfants malades, Assistance Publique-Hôpitaux de Paris, Paris France. 15 16 Corresponding Author : 17 Dr Jean Bergounioux 18 Réanimation et soins intensifs pédiatriques, Batiment Letulle, 3iém étage 19 Hôpital universitaire Raymond Poincaré, APHP, 104 Boulevard Raymond Poincaré, 92380 20 Garches, France 21 Phone: 01 47 10 79 00 DECT 41131 22 Fax: 01 47 10 68 93 23 Email: [email protected] 24 IAI Accepted Manuscript Posted Online 1 August 2016 Infect. Immun. doi:10.1128/IAI.00420-16 Copyright © 2016, American Society for Microbiology. All Rights Reserved. on May 21, 2018 by guest http://iai.asm.org/ Downloaded from

6 Jean Bergounioux - Infection and Immunityiai.asm.org/content/early/2016/07/26/IAI.00420-16.full.pdf2 25 The authors declare n o funding , no conflict of interest and that no previous

Embed Size (px)

Citation preview

Page 1: 6 Jean Bergounioux - Infection and Immunityiai.asm.org/content/early/2016/07/26/IAI.00420-16.full.pdf2 25 The authors declare n o funding , no conflict of interest and that no previous

1

1

Experimental evidences of human 2

coronary microvasculature and myocardial tissue 3

bacterial colonization during meningococcemia. 4

5

Jean Bergounioux1,2,3, Mathieu Coureuil1,4, Emre Belli5, Mohamed Ly5, Michelle 6

Cambillau6, Nicolas Goudin7, Xavier Nassif1,4,8and Olivier Join-Lambert1,4,8. 7

8 9 10 1 INSERM, U1151, Institut Necker Enfants Malades, Paris, France.; 2Université Versailles Saint Quentin en Yvelines, Versailles France; 3Service 11 de Neurologie et Réanimation pédiatrique, Hôpital Raymond Poincaré, APHP, Garches, France; 4Université Paris Descartes, Sorbonne 12 Paris Cité, Paris, France; 5Centre Chirurgical Marie Lannelongue, Clamard, France; 6Service de Biochimie, Hôpital Européen George 13 Pompidou, APHP, Paris, France 7SFR-Necker Cell Imaging Plateform, Imagine Institut, Paris France 8Laboratoire de Microbiologie 14 Hôpital Necker-Enfants malades, Assistance Publique-Hôpitaux de Paris, Paris France. 15

16

Corresponding Author : 17

Dr Jean Bergounioux 18

Réanimation et soins intensifs pédiatriques, Batiment Letulle, 3iém étage 19

Hôpital universitaire Raymond Poincaré, APHP, 104 Boulevard Raymond Poincaré, 92380 20

Garches, France 21

Phone: 01 47 10 79 00 DECT 41131 22

Fax: 01 47 10 68 93 23

Email: [email protected] 24

IAI Accepted Manuscript Posted Online 1 August 2016Infect. Immun. doi:10.1128/IAI.00420-16Copyright © 2016, American Society for Microbiology. All Rights Reserved.

on May 21, 2018 by guest

http://iai.asm.org/

Dow

nloaded from

Page 2: 6 Jean Bergounioux - Infection and Immunityiai.asm.org/content/early/2016/07/26/IAI.00420-16.full.pdf2 25 The authors declare n o funding , no conflict of interest and that no previous

2

The authors declare no funding, no conflict of interest and that no previous presentation of 25

this work was presented elsewhere. 26

27

E-mail addresses : 28

[email protected]; [email protected]; [email protected]; 29

[email protected]; [email protected]; [email protected]; 30

[email protected]; [email protected] 31

32

33

34

Keywords from your manuscript : 35

Neisseria meningitidis, Purpura fulminans, Septic shock, sepsis induced cardiac 36

dysfunction, xenograft, myocardial tissue 37

38

39

40

41

42

43

44

45

46

47

48

49

on May 21, 2018 by guest

http://iai.asm.org/

Dow

nloaded from

Page 3: 6 Jean Bergounioux - Infection and Immunityiai.asm.org/content/early/2016/07/26/IAI.00420-16.full.pdf2 25 The authors declare n o funding , no conflict of interest and that no previous

3

Abstract : 50

51

Background : Meningococcal septic shock is associated with profound vasoplegia, early and 52

severe myocardial dysfunction and extended skin necrosis responsible for a specific clinical 53

entity designated Purpura fulminans (PF). PF represents 90% of fatal meningococcal 54

infections. One characteristic of meningococcal PF is the myocardial dysfunction that occurs 55

in the early phase of sepsis. Furthermore, hemodynamic studies have shown that the 56

prognosis of meningococcal sepsis is directly related to the degree of impairment of cardiac 57

contractility during the initial phase of the disease. 58

Methods : To gain insight into a potential interaction of Neisseria meningitidis with the 59

myocardial microvasculature, we modified a previously described humanized mice model by 60

grafting to SCID mice human myocardial tissue. We then infected the grafted mice with N. 61

meningitides (Nm). 62

Results : Using the humanized-SCID mouse model we demonstrated that N. meningitidis 63

targets the human myocardial tissue vasculature, leading to the formation of blood thrombi, 64

infectious vasculitis and vascular leakage. 65

Conclusions : These results suggest a novel mechanism of myocardial injury in the course of 66

severe Nm Sepsis that is likely to participate to primary myocardial dysfunction. 67

68

69

70

71

on May 21, 2018 by guest

http://iai.asm.org/

Dow

nloaded from

Page 4: 6 Jean Bergounioux - Infection and Immunityiai.asm.org/content/early/2016/07/26/IAI.00420-16.full.pdf2 25 The authors declare n o funding , no conflict of interest and that no previous

4

72

Introduction: 73

74

Neisseria meningitidis is a human pathogen responsible for life-threatening infections 75

such as septic shock and meningitis, mainly in children and young adults [1]. Meningococcal 76

septic shock is associated with profound vasoplegia, early and severe myocardial dysfunction, 77

and extended skin necrosis responsible for a specific clinical entity designated Purpura 78

fulminans (PF). PF represents 90% of severe meningococcal infection fatal cases [2]. 79

80

Approximately 60% of patients admitted to intensive care units for severe sepsis or 81

septic shock present a clinical picture of cardiac dysfunction responsible for a mortality 82

ranging from 70 to 90%. On the other hand, mortality is 20% in septic patients without 83

cardiovascular involvement [3,4]. A specificity of meningococcal PF is the myocardial 84

dysfunction that occurs in the early phase of the sepsis and is often present from the start 85

[5,6]. By contrast, myocardial dysfunction appears during the late phase of sepsis with septic 86

shock caused by other Gram-negative infections. Furthermore, hemodynamic studies have 87

shown that the prognosis of meningococcal sepsis is directly related to the degree of 88

impairment of cardiac contractility during the initial phase of the disease [7,8]. 89

90

N. meningitidis (Nm) interacts with endothelial cells of the microvasculature 91

throughout the body [9,10]. Nm forms micro colonies on the apical surface of endothelial 92

cells and manipulates cell signaling pathways to disrupt cellular and endothelial tissue 93

architectures, eventually cross the vascular endothelium and colonize the surrounding tissue 94

or the adjacent organ [10-12]. A direct interaction of Nm with the myocardial tissue and 95

on May 21, 2018 by guest

http://iai.asm.org/

Dow

nloaded from

Page 5: 6 Jean Bergounioux - Infection and Immunityiai.asm.org/content/early/2016/07/26/IAI.00420-16.full.pdf2 25 The authors declare n o funding , no conflict of interest and that no previous

5

vasculature has not been demonstrated but strongly suspected. Indeed, postmortem 96

examination showed the presence of meningococci in the myocardial tissue associated with 97

histological features of myocarditis [13]. To gain insight into a potential interaction of Nm 98

with the myocardial microvasculature, we modified a previously described humanized mice 99

model by grafting to SCID mice human myocardial tissue [14]. Using this humanized SCID-100

mouse model we demonstrated that N. meningitidis targets the human myocardial tissue 101

vasculature, leading to the formation of blood thrombi, infectious vasculitis and vascular 102

leakage. These results suggest a novel mechanism of myocardial tissue injury in the course 103

of severe Nm Sepsis that is likely to participate to primary myocardial dysfunction. 104

105

106

Materials and Methods: 107

108

Bacterial Strains 109

We used the serogroup C meningococcal strain designated 2C4.3, and a nonpiliated isogenic 110

derivative (Nm ΔpilE) that was constructed by inserting a kanamycin resistance cassette in 111

the pilE gene locus [15]. The N. meningitidis strain 2C4.3, also known as clone 12 of the 112

clinical N. meningitidis strain LNP8013, is a naturally occurring pilin antigenic variant of the 113

original clinical isolate LNP8013, which expresses a pilin variant responsible for a high 114

adhesive phenotype (REF). N. meningitidis strains were stored frozen at −80°C in Giolitti-115

Cantoni broth (GCB) supplemented with 20% glycerol. 116

117

Mice 118

Six week-old CB17/Icr-Prkdcscid/IcrIcoCrl SCID female mice were purchased from Charles 119

on May 21, 2018 by guest

http://iai.asm.org/

Dow

nloaded from

Page 6: 6 Jean Bergounioux - Infection and Immunityiai.asm.org/content/early/2016/07/26/IAI.00420-16.full.pdf2 25 The authors declare n o funding , no conflict of interest and that no previous

6

River Laboratories (Saint Germain sur l’Arbresle, France). Experimental procedures were 120

performed in sterile conditions, and in accordance with the guidelines of the Institut 121

National de la Santé et de la Recherche Médicale (INSERM). The experimental protocol was 122

approved by the Animal Experimentation Ethics Committee of the Université Paris Descartes 123

(study registered under number 00309.0.02). 124

125

Graft Protocol 126

We used the experimental model described by Yan et al [14] that was initially designed to 127

study the expression and role of endothelial cell adhesion molecules for white blood cell 128

migration. Myocardial tissues were obtained from pediatric patients undergoing cardiac 129

surgery with myomectomy for left ventricular outflow tract obstruction in the Centre 130

Chirurgical Marie Lannelongue (Clamard, France). In accordance with French legislation, 131

human myocardial samples were obtained from patients whom legal tutors were informed 132

and did not refuse to participate in the study. The myocardial tissue was maintained on ice 133

cold cardioplegia medium (Custodiol® HTK Registered Trademark of Dr Franz Köhler Chemie 134

GmbH). Myocardial tissues were grafted under the back skin of SCID mice [16]. Briefly, mice 135

were prepared for transplantation by shaving the hair of the back and abdominal areas after 136

an intraperitoneal injection of ketamine 100 mg/kg and xylazine 10 mg/kg using a pair of 137

sponge forceps. Human Myocardial tissue was placed onto the wound bed. The transplants 138

were held in place with 6-0 non-absorbable monofilament suture materials, and the skin was 139

then sutured above the transplant. Grafted mice were used for N. meningitidis infection 140

experiments 15 days after human myocardial tissue transplantation. 141

142

Infection Protocol and Bacterial Counts 143

on May 21, 2018 by guest

http://iai.asm.org/

Dow

nloaded from

Page 7: 6 Jean Bergounioux - Infection and Immunityiai.asm.org/content/early/2016/07/26/IAI.00420-16.full.pdf2 25 The authors declare n o funding , no conflict of interest and that no previous

7

In vivo, iron-binding proteins such as transferrin and lactoferrin restrict the amount of ferric 144

iron available in body fluids to a level that does not support meningococcal growth [17]. To 145

counteract these iron-deficient conditions, N. meningitidis has several iron acquisition 146

systems, such as transferrin binding proteins A and B that are expressed when bacteria are 147

grown under iron-deficient conditions [18]. These receptors are specific of human 148

transferrin, therefore, bacterial strains were grown under iron-deficient conditions before 149

each infectious challenge, and human holotransferrin was added to the bacterial inoculum 150

to optimize bacterial growth in vivo [19, 20]. N. meningitidis strains were grown overnight at 151

37°C on GCB agar plates prepared without iron and supplemented with deferoxamine 152

(Desferal, Novartis) at a final concentration of 15 μM. Kanamycin (100 μg/mL) was added to 153

the medium to grow the kanamycin resistant ΔpilE strain. Bacterial colonies were harvested 154

and cultured in RPMI with 1% bovine serum albumin medium and 0.06 μM deferoxamine 155

with gentle agitation to reach the exponential growth phase. Bacteria were then 156

concentrated by centrifugation and resuspended in physiological saline containing 20 mg/mL 157

of human holotransferrin to promote bacterial growth in vivo (2914HT, R&D systems) [18]. 158

Preliminary experiments showed that a 100-fold-higher inoculum was necessary to obtain a 159

sustained bacteremia by intravenous injection of bacteria, as compared to intraperitoneal 160

route (data not shown). Mice were infected intraperitoneally with 0.5 mL of this bacterial 161

suspension. To assess bacteremia in infected animals, 10 μL of blood was sampled using a 162

heparinized hematocrit glass tube after puncture or the lateral tail vein, or at the time of 163

death by intracardiac puncture after intraperitoneal injection of a lethal dose of ketamine 164

and xylazine. 165

166

Bacterial counts were performed by plating serial dilutions of blood or of myocardial tissue 167

on May 21, 2018 by guest

http://iai.asm.org/

Dow

nloaded from

Page 8: 6 Jean Bergounioux - Infection and Immunityiai.asm.org/content/early/2016/07/26/IAI.00420-16.full.pdf2 25 The authors declare n o funding , no conflict of interest and that no previous

8

graft homogenates on GCB agar plates. Results were expressed in colony-forming units (CFU) 168

per mL of blood. 169

170

Histology and immunofluoresence 171

172

Mice were killed 24 hours after infection. Mouse myocardial tissue grafts and mouse heart 173

were removed, fixed in 10% buffered formalin and embedded in paraffin. Hematoxylin, 174

eosin, and safranin staining and immunofluorescence labeling were performed on 5-μm 175

tissue sections using the Leica BOND-MAX automated system (Leica-microsystems, Wetzlar, 176

Germany). Tissues were fixed overnight in PBS 4% PFA. Cells were incubated with 177

primary antibodies at the recommended concentration in PBS containing 0.3% BSA for 1 178

hr. After 3 washings in the same buffer, Alexa-conjugated phalloidin and DAPI (0.5 179

μg/ml) were added to Alexa-conjugated secondary antibodies for 1 hr. After additional 180

washings, coverslips were mounted in mowiol. 181

For fluorescence microscopy the following reagents were used: Polyclonal anti PilE 182

antiserum. Secondary antibodies used were: antirabbit Alexa 56. All samples were mounted 183

in Vectashield mounting reagent (Vector Laboratories, Eurobio ABCys, France). 184

Image acquisition was performed on a structured illumination microscope (Apotome 2 185

Zeiss) with a 63x (NA 1.4) oil objectives. Images were collected using the Zen 2012 186

(Zeiss) software. Figures were performed using Fiji (v 1.43) software and FigureJ (v 1.) 187

plugin. Final figures were created in Photoshop (Adobe, USA). 188

189

190

191

on May 21, 2018 by guest

http://iai.asm.org/

Dow

nloaded from

Page 9: 6 Jean Bergounioux - Infection and Immunityiai.asm.org/content/early/2016/07/26/IAI.00420-16.full.pdf2 25 The authors declare n o funding , no conflict of interest and that no previous

9

Results: 192

193

Human Myocardial tissue Xenograft in SCID mice is revascularized by mouse’s vessels: 194

195

N. meningitidis does not interact with non-human cells. In order to study the consequences 196

of a potential interaction between N. meningitidis and myocardial microvasculature we 197

modified a previously described humanized mouse model by grafting human myocardial 198

tissue to SCID mice. Human myocardial tissues were obtained from pediatric patients 199

undergoing cardiac surgery with myomectomy for left ventricular outflow tract obstruction 200

and were grafted less than 2 hours after surgical removal. Our first goal was to assess 201

whether the vascularization of human myocardial tissues connect with that of the mouse as 202

it is the case for human skin graft. As shown in Figure 1a the macroscopic aspect of the graft 203

at day 14 was satisfying showing a well-vascularized tissue. Histological microscopic analysis 204

of the graft showed a normal vascularization with healthy cardiomyocytes surrounding the 205

vessels. The architecture of cardiac cells and cardiac tissue were preserved and there was no 206

evidence of inflammatory cells infiltrates into the graft tissue (Figure 1b). The vessels 207

present in the graft are all microvessels with a diameter inferior to 300µm and all of them 208

presented the structure of a vein or a capillary with thin vascular wall without layer of 209

smooth muscle cells. We conclude that human myocardial tissue xenotransplanted into SCID 210

mice are efficiently revascularized tissue displays characteristics of human myocardial tissue. 211

212

Neisseria meningitidis colonizes the myocardium venous and capillary microvessels 213

214

Grafted mice were subsequently infected using 106 CFU IP as this inoculum produced 215

on May 21, 2018 by guest

http://iai.asm.org/

Dow

nloaded from

Page 10: 6 Jean Bergounioux - Infection and Immunityiai.asm.org/content/early/2016/07/26/IAI.00420-16.full.pdf2 25 The authors declare n o funding , no conflict of interest and that no previous

10

reproducible high and sustained bacteremia in infected animals. Twenty-four hours after 216

infection, animals were sacrificed. At this time, the explanted grafts were colored and well 217

perfused with a healthy aspect of the tissue. 218

Human myocardial tissue grafts were sampled and analyzed. All the vessels were colonized 219

by N. meningitidis, while extracellular bacteria adhering to the intraluminal surface of 220

endothelial cells of myocardial tissue microcirculation were seen in all human myocardial 221

tissue graft sampled from infected animals (3/3 myocardial tissue grafts obtained from 3 222

different experiments) (Figure 2,4 and 5). All the colonized vessels were capillaries or 223

venules with a thin wall. N. meningitidis is disposed as a layer of several strata of bacteria 224

uniformly distributed on the inner face of the vessel. Bacteria underlined the entire 225

endoluminal surface of vessels, or in some circumstances completely occluded the vascular 226

lumen (Figure 2a and 2b). 227

It should be pointed out that Hematoxylin, eosin, and safranin staining of sections containing 228

both human myocardial tissue graft and subcutaneous mouse paniculus carnosus 229

demonstrated that N. meningitidis interacted specifically with human graft vessels (Figure 3). 230

Furthermore, hearts of infected animals were sampled at the same time as the graft and 231

prepared following the same protocol and did not show any vascular colonization by Nm, as 232

expected (data not shown). Altogether these data demonstrated a specific interaction of Nm 233

with the human myocardial vessels. 234

235

236

N. meningitidis myocardium vascular colonization induced intravascular thrombosis and 237

vascular endothelial destruction as well as vasculitis. 238

239

on May 21, 2018 by guest

http://iai.asm.org/

Dow

nloaded from

Page 11: 6 Jean Bergounioux - Infection and Immunityiai.asm.org/content/early/2016/07/26/IAI.00420-16.full.pdf2 25 The authors declare n o funding , no conflict of interest and that no previous

11

240

Two different types of vascular lesions were observed in the myocardial tissue xenograft. 241

(i) The most frequent type of vascular lesion (type I) were vessel occlusions by infectious 242

clots (75% on a count of 100 vessels) which was mainly observed in vessels having an 243

average diameter of 20µm. These clots are composed by the aggregation of fibrin, blood 244

cells and bacteria (Fig 2). Only few vessels of the graft did not present any histological lesion 245

(8% on a count of 100 vessels). This septic clot had a very peculiar organization. The red 246

blood cells and fibrin clots were central to the vessel’s lumen and surrounded by a layer of 247

bacteria adhering to the vascular endothelium (Figure 4). The clots structural organization 248

suggests that the clot formation followed a centripetal process from the endothelium to the 249

center of the vessel. This organization suggests that the bacterial interaction with the 250

endothelium triggered the clotting process leading to the blood clot formation. 251

(ii) Another type of vascular lesion (type II) was observed less frequently (17% on a count of 252

100 vessels), was characterized by smaller vessels with an average size of 15 µm (count of 253

100 vessels). These lesions corresponded to vasculitis with massive infiltration by 254

polymorphonuclear cells (PMN), with a destruction of the vascular wall and disappearance 255

of the vascular lumen (Figure 5a and 5b). Unlike what was seen in the type I lesions, few 256

bacteria or bacterial clots are visible in these lesions. This loss of vascular wall integrity 257

results in vascular leakage leading to red cells getting in the perivascular space (Figure 4b). 258

It should be pointed out that in only 8% of the vessels no lesions was observed. 259

260

In many occurrences but specially in type II lesions, N. meningitidis was found outside of the 261

vascular lumen, in the myocardial tissue surrounding the vessels accompanied by red blood 262

cells, which indicated an endothelial rupture (Figure 4a and 4b). These images resembled 263

on May 21, 2018 by guest

http://iai.asm.org/

Dow

nloaded from

Page 12: 6 Jean Bergounioux - Infection and Immunityiai.asm.org/content/early/2016/07/26/IAI.00420-16.full.pdf2 25 The authors declare n o funding , no conflict of interest and that no previous

12

those described in skin purpuric lesions characteristic of the meningococcal purpura 264

fulminans [9]. Moreover, some bacteria were localized between the vessels and most 265

frequently in close proximity to polymorphonuclear cells (Fig 4c and Fig 5b). The colonization 266

of the surrounding tissues by N. meningitidis is clearly visible adjacent to the vessels (Figures 267

4c and 5b). 268

269

N. meningitidis adhesion to endothelial cells of the coronary microvascularisation and 270

infectious vasculitis require Type IV pilus 271

272

Type IV pili have a central role in meningococcal pathogenesis [15]. In vitro and in 273

vivo meningococcal adhesion to human endothelial cells has been shown to require Type IV 274

Pili. We subsequently tested the ability of a capsulated non-piliated derivative of N. 275

meningitidis 2C4.3 (ΔpilE) to target the human myocardial tissue graft vasculature. As shown 276

Figure 6, the non-piliated strain failed to target the human myocardial tissue graft as 277

demonstrated by the absence of bacteria sticking to the vessels endothelium. In addition, no 278

thrombosis nor vascular lesion was observed in the graft microvasculature when infected by 279

the non-piliated strain, thus demonstrating that the histologic lesions observed in the 280

vasculature of grafts infected with wild type N. menigitidis are type IV pilus dependent. 281

282

Discussion: 283

284

The model allowed, for the first time, an analysis of the intimate relations between N. 285

meningitidis, coronary microcirculation and myocardial tissue in vivo. Our results showed 286

that N. meningitidis adhere to the myocardium micro-vessel’s wall and induced a septic 287

on May 21, 2018 by guest

http://iai.asm.org/

Dow

nloaded from

Page 13: 6 Jean Bergounioux - Infection and Immunityiai.asm.org/content/early/2016/07/26/IAI.00420-16.full.pdf2 25 The authors declare n o funding , no conflict of interest and that no previous

13

vasculitis of the coronary microcirculation. Moreover, N. meningitidis induced septic 288

thrombosis of the micro vessels followed by a destruction of the vascular endothelium. The 289

damages observed resembled those observed in the skin of patients with meningococcemia. 290

Vascular lesions were similar to those described in patient’s skin purpuric lesions specific of 291

Purpura Fulminans, including thrombosis of vessels, perivascular infiltrates, and vascular 292

leakage (Figure 4) [10]. Inflammatory cells, including mononuclear cells and neutrophils 293

surrounded capillaries located in the superficial and mid dermis and infiltrated their walls 294

(Figure 2A and 2B). A mutant of N. meningitidis, defective for the pilin PilE, did not cause any 295

vasculitis, demonstrating that Type IV pilin is required for vasculitis. 296

297

Our results give experimental evidences that a direct interaction between N. 298

meningitidis and the heart takes place. To our knowledge, this represents the first report of 299

myocardial tissue colonization by bacteria. Moreover, our findings corroborate the 300

observations made by Monsalve et al. obtained from postmortem examination of three 301

patients suffering of meningococcemia showing the presence of myocarditis associated with 302

the presence of Gram-negative diplococci [13]. From this study it was hypothesized that N. 303

meningitidis colonize the myocardial tissue and induce tissue inflammation. Considering our 304

results, it is likely that the mechanism of this colonization is an infectious vasculitis of the 305

coronary microvascularisation. Destruction of the vascular endothelium allowed N. 306

meningitidis to enter the myocardial tissue generating neutrophils inflow and subsequent 307

local inflammation. 308

309

Diverse mechanisms underlying septic myocardial depression have been described 310

[21,22]. Sepsis-induced cardiomyopathy appears to be an excessive physiological adaptation 311

on May 21, 2018 by guest

http://iai.asm.org/

Dow

nloaded from

Page 14: 6 Jean Bergounioux - Infection and Immunityiai.asm.org/content/early/2016/07/26/IAI.00420-16.full.pdf2 25 The authors declare n o funding , no conflict of interest and that no previous

14

of the heart function to the sepsis and not a myocardial tissue injury. Indeed, clinical studies 312

have shown a specific hemodynamic profile of the sepsis induced cardiac depression, i.e. a 313

transient and global defect of the heart function, sometimes profound, followed by full 314

recovery [23]. It was shown that myocardial ischemia and necrosis are not the mechanisms 315

of myocardial septic dysfunction, the main hypothesis being a massive signaling to the heart 316

muscle. This signaling would be responsible for hibernation-like conditions where the 317

myocardial muscle down regulates its function in order to reduce energy expenditure, thus 318

preventing activation of cell death pathways of cardiomyocytes [22,24]. Endotoxins, Toll like 319

receptors (TLR) and cytokines mediate this signaling. Cytokines are produced and liberated 320

from activated immune cells after contact with bacterial compounds. The signaling is 321

systemic, via cytokine, as well as local, via TLR4 activation, leading to myocardial septic 322

dysfunction [22,24]. TLR4 must be present on macrophage and neutrophils to cause myocyte 323

dysfunction during endotoxemia [25,27]. Interleukin 6 has been shown to have an important 324

role in myocardial depressant activity in children with meningococcal septic shock [6]. Our 325

results, showing a massive presence of N. meningitidis in the coronary microvascularisation 326

as well as in myocardial tissue, suggest that N. meningitidis septicemia may be associated 327

with strong local signaling. Massive stimulation of the TLRs by N. meningitidis emphasizes by 328

the local septic thrombi and increased concentration of N. meningitidis LPS analog due to 329

endothelium adherence of the bacteria could generate such antigenic stimulation resulting 330

in strong innate immune signaling and myocardial dysfunction. Polynuclear infiltration of the 331

myocardial muscle has been demonstrated of critical importance in the TLR4 mediated 332

contractile dysfunction induced by sepsis [27]. Polynuclear infiltration is present in almost 333

20% of the vessels analyzed in our model and may also participate to myocardial dysfunction. 334

This model will help to provide a better understanding of the septic myocardial depression 335

on May 21, 2018 by guest

http://iai.asm.org/

Dow

nloaded from

Page 15: 6 Jean Bergounioux - Infection and Immunityiai.asm.org/content/early/2016/07/26/IAI.00420-16.full.pdf2 25 The authors declare n o funding , no conflict of interest and that no previous

15

induced by N. meningitidis but mouse and human differences in complement, binding 336

receptors, and signaling receptors would probably limit its exploitation at the molecular level. 337

338

In the case of severe meningococcal infection, our results showed vascular damages 339

of the coronary microcirculation, presence of massive amount of LPS and infiltration of 340

polymorphonuclear cells and bacteria in the myocardial tissue. Indeed, the histological 341

lesions of the coronary microcirculation observed in our model are mimicking the lesions 342

observed at the skin level in purpura fulminans. The results of our ex vivo experiments 343

suggest that these damages participate to the specificity of the N. meningitidis associated 344

sepsis-induced cardiomyopathy that take place early in the course of the disease and is 345

usually severe. The exact nature of the signaling and its consequences would need further 346

investigation but the trigger of the vascular damages appears to be linked to the presence of 347

type IV pili. Indeed the role of type IV pili in the disorganization of the cell-cell junctions and 348

in the opening of paracellular route in the brain capillaries has already been shown to allow 349

N. meningitidis to cross the blood brain barrier and invade the meninges and in the skin 350

capillaries to induce the skin lesions typical of the disease (Figure 6) [10,12]. All together, 351

these results may explain the early and profound septic cardiac dysfunction associated to N 352

meningitidis septic shock. 353

354

355

Conclusion: 356

357

We describe for the first time a model of human cardiac muscle tissue xenograft in 358

SCID mice providing a new tool to study intimate interaction of human pathogens with the 359

on May 21, 2018 by guest

http://iai.asm.org/

Dow

nloaded from

Page 16: 6 Jean Bergounioux - Infection and Immunityiai.asm.org/content/early/2016/07/26/IAI.00420-16.full.pdf2 25 The authors declare n o funding , no conflict of interest and that no previous

16

human heart. Our work demonstrates the tropism of N. meningitidis for human coronary 360

microcirculation in vivo, and its pilus-mediated specificity. This interaction with human 361

coronary microcirculation may play a role in the profound and early cardiac dysfunction that 362

classically goes with severe meningococcal sepsis. Our model will allow a better 363

understanding of the pathogenesis of septic heart dysfunction and will open the path to 364

specific treatments of this major complication of severe meningococcal sepsis. 365

366

367

Acknowledgments: We thank Virginie Lambert, Catherine Rucker, Gérard Pivert, Omar Aimer, 368

John Rohde and Isabelle Le Maner for technical assistance and advice. 369

370

371

372

Bibliography: 373

374

1- Stephens DS, Greenwood B, Brandtzaeg P. Epidemic meningitis, meningococcaemia and Neisseria 375

meningitidis. Lancet 2007; 369:2196–210. 376

2- De Greeff SC, de Melker HE, Schouls LM, Spanjaard L, van Deuren M. Pre-admission clinical course of 377

meningococcal disease and opportunities for the earlier start of appropriate intervention: a prospective 378

epidemiological study on 752 patients in the Netherlands, 2003-2005. Eur J Clin Microbiol Infect Dis. 2008 379

Oct;27(10):985-92 380

3- Vieillard-Baron A, Caille V, Charron C, Belliard G, Page B, Jardin F. Actual incidence of global left ventricular 381

hypokinesia in adult septic shock. Crit Care Med. 2008 Jun;36(6):1701-6. 382

on May 21, 2018 by guest

http://iai.asm.org/

Dow

nloaded from

Page 17: 6 Jean Bergounioux - Infection and Immunityiai.asm.org/content/early/2016/07/26/IAI.00420-16.full.pdf2 25 The authors declare n o funding , no conflict of interest and that no previous

17

4- Makwana N, Baines PB. Myocardial dysfunction in meningococcal septic shock. Curr Opin Crit Care. 2005 383

Oct;11(5):418-23. Review. 384

385

5- Thiru Y, Pathan N, Bignall S, Habibi P, Levin M. A myocardial cytotoxic process is involved in the cardiac 386

dysfunction of meningococcal septic shock. Crit Care Med. 2000 Aug;28(8):2979-83. 387

6- Pathan N, Hemingway CA, Alizadeh AA, Stephens AC, Boldrick JC, Oragui EE, McCabe C, Welch SB, Whitney A, 388

O'Gara P, Nadel S, Relman DA, Harding SE, Levin M. Role of interleukin 6 in myocardial dysfunction of 389

meningococcal septic shock. Lancet. 2004 Jan 17;363(9404):203-9. 390

7- Boucek MM, Boerth RC, Artman M, Graham TP Jr, Boucek RJ Jr. Myocardial dysfunction in children with 391

acute meningococcemia. J Pediatr. 1984 Oct;105(4):538-42. 392

8- Pathan N, Faust SN, Levin M. Pathophysiology of meningococcal meningitis and septicaemia. Arch Dis Child. 393

2003 Jul;88(7):601-7. Review. 394

9- Bernard SC, Simpson N, Join-Lambert O, Federici C, Laran-Chich MP, Maïssa N, Bouzinba-Ségard H, Morand 395

PC, Chretien F, Taouji S, Chevet E, Janel S, Lafont F, Coureuil M, Segura A, Niedergang F, Marullo S, Couraud PO, 396

Nassif X, Bourdoulous S. Pathogenic Neisseria meningitidis utilizes CD147 for vascular colonization. Nat Med. 397

2014 Jul;20(7):725-31. doi: 10.1038/nm.3563. Epub 2014 Jun 1. 398

10- Join-Lambert O, Lecuyer H, Miller F, Lelievre L, Jamet A, Furio L, Schmitt A, Pelissier P, Fraitag S, Coureuil M, 399

Nassif X. Meningococcal interaction to microvasculature triggers the tissular lesions of purpura fulminans. J 400

Infect Dis. 2013 Nov 15;208(10):1590-7. doi: 10.1093/infdis/jit301. Epub 2013 Jul 9. 401

11- Coureuil M, Lécuyer H, Scott MG, Boularan C, Enslen H, Soyer M, Mikaty G, Bourdoulous S, Nassif X, 402

Marullo S. Meningococcus Hijacks a β2-adrenoceptor/β-Arrestin pathway to cross brain microvasculature 403

endothelium. Cell. 2010 Dec 23;143(7):1149-60. doi: 10.1016/j.cell.2010.11.035. 404

on May 21, 2018 by guest

http://iai.asm.org/

Dow

nloaded from

Page 18: 6 Jean Bergounioux - Infection and Immunityiai.asm.org/content/early/2016/07/26/IAI.00420-16.full.pdf2 25 The authors declare n o funding , no conflict of interest and that no previous

18

12- Coureuil M, Mikaty G, Miller F, Lécuyer H, Bernard C, Bourdoulous S, Duménil G, Mège RM, Weksler BB, 405

Romero IA, Couraud PO, Nassif X. Meningococcal type IV pili recruit the polarity complex to cross the brain 406

endothelium. Science. 2009 Jul 3;325(5936):83-7. doi: 10.1126/science.1173196. Epub 2009 Jun 11. 407

13- Monsalve F, Rucabado L, Salvador A, Bonastre J, Cuñat J, Ruano M. Myocardial depression in septic shock 408

caused by meningococcal infection. Crit Care Med. 1984 Dec;12(12):1021-3. 409

14- Yan HC, Juhasz I, Pilewski J, Murphy GF, Herlyn M, Albelda SM. Human/severe combined immunodeficient 410

mouse chimeras. An experimental in vivo model system to study the regulation of human endothelial cell-411

leukocyte adhesion molecules. J Clin Invest 1993; 91:986–96. 412

15- Nassif X, Lowy J, Stenberg P, O’Gaora P, Ganji A, So M. Antigenic variation of pilin regulates adhesion of 413

Neisseria meningitidis to human epithelial cells. Mol Microbiol 1993; 8:719–25. 414

16- Barrandon Y, Li V, Green H. New techniques for the grafting of cultured human epidermal cells onto 415

athymic animals. J Invest Dermatol 1988; 91:315–8. 416

17- Calver GA, Kenny CP, Kushner DJ. Inhibition of the growth of Neisseria meningitidis by reduced ferritin and 417

other iron-binding agents. Infect Immun 1979; 25:880–90. 418

18- Simonson C, Brener D, DeVoe IW. Expression of a high-affinity mechanism for acquisition of transferrin iron 419

by Neisseria meningitidis. Infect Immun 1982; 36:107–13. 420

19- Holbein BE. Iron-controlled infection with Neisseria meningitidis in mice. Infect Immun 1980; 29:886–91. 421

20- Holbein BE. Enhancement of Neisseria meningitidis infection in mice by addition of iron bound to 422

transferrin. Infect Immun 1981; 34:120–5. 423

424

21- Zaky A1, Deem S, Bendjelid K, Treggiari MM. Characterization of cardiac dysfunction in sepsis: an ongoing 425

challenge. Shock. 2014 Jan;41(1):12-24. 426

on May 21, 2018 by guest

http://iai.asm.org/

Dow

nloaded from

Page 19: 6 Jean Bergounioux - Infection and Immunityiai.asm.org/content/early/2016/07/26/IAI.00420-16.full.pdf2 25 The authors declare n o funding , no conflict of interest and that no previous

19

22- Rudiger A, Singer M. Mechanisms of sepsis-induced cardiac dysfunction. Crit Care Med. 2007 427

Jun;35(6):1599-608. Review. 428

23- Parker MM, Shelhamer JH, Bacharach SL, Green MV, Natanson C, Frederick TM, Damske BA, Parrillo JE. 429

Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med. 1984 430

Apr;100(4):483-90. 431

24- Rudiger A, Singer M. The heart in sepsis: from basic mechanisms to clinical management. Curr Vasc 432

Pharmacol. 2013 Mar 1;11(2):187-95. Review. 433

25- Arslan F, de Kleijn DP, Pasterkamp G. Innate immune signaling in cardiac ischemia. Nat Rev Cardiol. 2011 434

May;8(5):292-300. doi: 10.1038/nrcardio.2011.38. Epub 2011 Mar 29. Review. 435

26- Baumgarten G, Knuefermann P, Schuhmacher G, Vervölgyi V, von Rappard J, Dreiner U, Fink K, Djoufack C, 436

Hoeft A, Grohé C, Knowlton AA, Meyer R. Toll-like receptor 4, nitric oxide, and myocardial depression in 437

endotoxemia. Shock. 2006 Jan;25(1):43-9. 438

27- Tavener SA, Long EM, Robbins SM, McRae KM, Van Remmen H, Kubes P. Immune cell Toll-like receptor 4 is 439

required for cardiac myocyte impairment during endotoxemia. Circ Res. 2004 Oct 1;95(7):700-7. Epub 2004 Sep 440

Figure legends: 441

Figure 1: (a) viability of the myocardial tissue xenograft macroscopic aspect. (b): viability of the myocardial 442

tissue xenograft microscopic aspect. Eosin-hematoxilin coloration of the control graft showing normal 443

myocardial muscular cells and normal myocardial muscle architecture. Graft vessels of human origin are 444

perfused by red cells of mouse origin. 445

Figure 2: (a) Control graft of the non-infected animal showing a normal vessel of human origin in the graft tissue 446

with circulating red blood cells of mice origin in its lumen. (b) This image shows graft vessel from infected 447

animal with central infectious clot occupying the entire lumen of the vessel and large amount of bacteria 448

localized inside the clot and on the vessel internal surface. 449

on May 21, 2018 by guest

http://iai.asm.org/

Dow

nloaded from

Page 20: 6 Jean Bergounioux - Infection and Immunityiai.asm.org/content/early/2016/07/26/IAI.00420-16.full.pdf2 25 The authors declare n o funding , no conflict of interest and that no previous

20

Figure 3: the arrow 1 is in the human graft showing a human vessel infiltrated by polynuclear cells and a total 450

loss of the vessel architecture; the arrow 2 is in mouse surrounding tissue showing a mouse vessel of normal 451

aspect emphasizing the human specificity of Nm infection and vasculitis. 452

Figure 4: (a) This image shows a vessel occluded by a septic thrombus composed of meningococcus and a clot 453

of fibrin and platelets. The arrow 1 shows the central clot mainly composed of red cells; the arrow 2 shows the 454

ring of meningococci surrounding the clot; the arrow 3 shows meningococci outside of the vascular lumen. (b) 455

This image shows a vessel occluded by a septic thrombus composed of meningococcus and a clot of fibrin and 456

platelets with vascular lumen filed by the meningococci. The arrow 1 shows the central clot mainly composed of 457

red cells; the arrow 2 shows the ring of meningococci surrounding the clot; the arrow 3 shows a rupture in the 458

vascular endothelium with red cells and bacteria passing in the surrounding tissue. (c) This image shows 459

multiple fields reconstruction of apotome acquisitions (4 x 2); scale bare is 20 μm; upper left image: tissue 460

imaging using transmitted light; upper right image: circling of the blood vessels; lower left image: Apotome 461

imaging of the DAPI (blue) and 2C43 antibody (red); White arrows show N meningitidis present in the 462

surrounding tissue; lower right image showing a magnification of the lower left image rectangular selection with 463

central clot circled by a ring of N. meningitidis. 464

Figure 5: (a) This image shows massive infiltration of two vessels by polynuclear cells that results into the loss 465

of their architecture and the surrounding tissue. (b) This image shows multiple fields reconstruction of apotome 466

acquisitions (4 x 2); scale bare is 20 μm; upper left image: tile scan tissue imaging using transmitted light; 467

upper right image: circling of the blood vessels; lower left image: Apotome imaging of the DAPI (blue) and 468

2C43 antobody (red); lower right image showing a magnification of the lower left image rectangle with a 469

massive infiltration of the vessel by the PMN. White arrows show N meningitidis present in the surrounding 470

tissue. 471

Figure 6: Upper figure shows control graft with no infection. Central figure shows infection with isogenic 472

mutant (Nm ΔpilE) showing normal graft vessels and no inflammatory cells. Lower figure showing infection 473

with wild strain 2C4.3 showing N. meningitidis underlining the vascular endothelium (see black arrow). Graph a 474

showed similar levels of bacteremia in mice at H1 and H6 after infection with the wild-type 2C4.3 N. 475

meningitidis strain or with the Δ pilE derivative of 2C4.3 (p = ns) (2 mice per group). Graph b showed the 476

bacterial load of myocardial graft was lower in mice infected with the non piliated strain 24 hours after infection 477

(1 sample of myocardial tissue analyzed for both condition). 478

on May 21, 2018 by guest

http://iai.asm.org/

Dow

nloaded from

Page 21: 6 Jean Bergounioux - Infection and Immunityiai.asm.org/content/early/2016/07/26/IAI.00420-16.full.pdf2 25 The authors declare n o funding , no conflict of interest and that no previous

on May 21, 2018 by guest

http://iai.asm.org/

Dow

nloaded from

Page 22: 6 Jean Bergounioux - Infection and Immunityiai.asm.org/content/early/2016/07/26/IAI.00420-16.full.pdf2 25 The authors declare n o funding , no conflict of interest and that no previous

on May 21, 2018 by guest

http://iai.asm.org/

Dow

nloaded from

Page 23: 6 Jean Bergounioux - Infection and Immunityiai.asm.org/content/early/2016/07/26/IAI.00420-16.full.pdf2 25 The authors declare n o funding , no conflict of interest and that no previous

on May 21, 2018 by guest

http://iai.asm.org/

Dow

nloaded from

Page 24: 6 Jean Bergounioux - Infection and Immunityiai.asm.org/content/early/2016/07/26/IAI.00420-16.full.pdf2 25 The authors declare n o funding , no conflict of interest and that no previous

on May 21, 2018 by guest

http://iai.asm.org/

Dow

nloaded from

Page 25: 6 Jean Bergounioux - Infection and Immunityiai.asm.org/content/early/2016/07/26/IAI.00420-16.full.pdf2 25 The authors declare n o funding , no conflict of interest and that no previous

on May 21, 2018 by guest

http://iai.asm.org/

Dow

nloaded from

Page 26: 6 Jean Bergounioux - Infection and Immunityiai.asm.org/content/early/2016/07/26/IAI.00420-16.full.pdf2 25 The authors declare n o funding , no conflict of interest and that no previous

on May 21, 2018 by guest

http://iai.asm.org/

Dow

nloaded from

Page 27: 6 Jean Bergounioux - Infection and Immunityiai.asm.org/content/early/2016/07/26/IAI.00420-16.full.pdf2 25 The authors declare n o funding , no conflict of interest and that no previous

on May 21, 2018 by guest

http://iai.asm.org/

Dow

nloaded from

Page 28: 6 Jean Bergounioux - Infection and Immunityiai.asm.org/content/early/2016/07/26/IAI.00420-16.full.pdf2 25 The authors declare n o funding , no conflict of interest and that no previous

on May 21, 2018 by guest

http://iai.asm.org/

Dow

nloaded from

Page 29: 6 Jean Bergounioux - Infection and Immunityiai.asm.org/content/early/2016/07/26/IAI.00420-16.full.pdf2 25 The authors declare n o funding , no conflict of interest and that no previous

on May 21, 2018 by guest

http://iai.asm.org/

Dow

nloaded from

Page 30: 6 Jean Bergounioux - Infection and Immunityiai.asm.org/content/early/2016/07/26/IAI.00420-16.full.pdf2 25 The authors declare n o funding , no conflict of interest and that no previous

on May 21, 2018 by guest

http://iai.asm.org/

Dow

nloaded from

Page 31: 6 Jean Bergounioux - Infection and Immunityiai.asm.org/content/early/2016/07/26/IAI.00420-16.full.pdf2 25 The authors declare n o funding , no conflict of interest and that no previous

on May 21, 2018 by guest

http://iai.asm.org/

Dow

nloaded from